In this regard, the plasma levels of MCP-1, IL-6, and TNF-α could be used as surrogate biomarkers in clinical trials evaluating autoimmune disorders that are associated with elevated levels of these cytokines, such as rheumatoid arthritis and psoriasis [36, 37]. The gene discussed is IL6; the disease is psoriasis.